Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MEI Pharma Inc (NASDAQ:MEIP)

1.36
Delayed Data
As of Jul 29
 -0.0001 / -0.01%
Today’s Change
0.87
Today|||52-Week Range
2.12
-15.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$47.1M

Company Description

MEI Pharma, Inc. is an oncology company, which engages in clinical development of novel small molecules for the treatment of cancer. Its portfolio of drug candidates includes Pracinostat, an oral inhibitor that is poised to enter a phase study for the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML). The company was founded on December 1, 2000 and is headquartered in San Diego, CA.

Contact Information

MEI Pharma, Inc.
11975 El Camino Real
San Diego California 92130-2541
P:(858) 792-6300
Investor Relations:
(858) 369-7199

Employees

Shareholders

Mutual fund holders6.33%
Other institutional14.88%
Individual stakeholders14.45%

Top Executives

Daniel P. GoldPresident, Chief Executive Officer & Director
Thomas M. ZechChief Financial Officer & Secretary
Robert D. MassChief Medical Officer
Ofir MorenoVice President-Research & Development
David M. UrsoSenior Vice President-Corporate Development